Literature DB >> 24283974

Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.

Craig J Thomas, John C McKew1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24283974      PMCID： PMC4337773          DOI： 10.2174/1568026613666131127125351

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN： 1568-0266            Impact factor:   3.295


× No keyword cloud information.
  9 in total

Review 1.  Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor.

Authors:  D D Richman
Journal:  Antivir Ther       Date:  2001-06

2.  The birth of biotechnology.

Authors:  Eugene Russo
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

3.  Ivacaftor.

Authors:  Pamela B Davis; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

4.  NCATS launches drug repurposing program.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

5.  Driving drug discovery: the fundamental role of academic labs.

Authors:  B Michael Silber
Journal:  Sci Transl Med       Date:  2010-05-05       Impact factor: 17.956

Review 6.  The importance of new companies for drug discovery: origins of a decade of new drugs.

Authors:  Robert Kneller
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

7.  Pemetrexed disodium.

Authors:  Mohamed Muhsin; Clair Gricks; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

8.  Pregabalin.

Authors:  Robert H Dworkin; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2005-06       Impact factor: 84.694

9.  A public-private partnership to unlock the untargeted kinome.

Authors:  Stefan Knapp; Paulo Arruda; Julian Blagg; Stephen Burley; David H Drewry; Aled Edwards; Doriano Fabbro; Paul Gillespie; Nathanael S Gray; Bernhard Kuster; Karen E Lackey; Paulo Mazzafera; Nicholas C O Tomkinson; Timothy M Willson; Paul Workman; William J Zuercher
Journal:  Nat Chem Biol       Date:  2013-01       Impact factor: 15.040
  9 in total
  5 in total

1.  Preclinical research strategies for newly approved drugs as reflected in early publication patterns.

Authors:  Ursula Köster; Ingo Nolte; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-26       Impact factor: 3.000

2.  Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.

Authors:  Marjan Amiri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-28       Impact factor: 3.000

3.  Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases.

Authors:  Felix Calderón; Lluis Ballell; David Barros; Graeme Bilbe; Nicholas Cammack; Raquel Gabarró; Audra Halsey; Penny M Heaton; Gagandeep Kang; Valerie Mizrahi; Carl Nathan; Mike E Strange; Pauline M Williams; Elizabeth A Winzeler; Alan H Fairlamb
Journal:  Nat Rev Drug Discov       Date:  2021-11       Impact factor: 84.694

4.  The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study.

Authors:  Mohua Chakraborty Choudhury; Gayatri Saberwal
Journal:  Orphanet J Rare Dis       Date:  2019-11-04       Impact factor: 4.123

Review 5.  Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review.

Authors:  Allen Li; Ming K Li; Mark Crowther; Sara R Vazquez
Journal:  Thromb Res       Date:  2020-08-11       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.